NAR
2011
13 years 2 months ago
2011
The protein common interface database (ProtCID) is a database that contains clusters of similar homodimeric and heterodimeric interfaces observed in multiple crystal forms (CFs). ...
NAR
2011
13 years 6 months ago
2011
The polyglutamine diseases are caused in part by a gain-of-function mechanism of neuronal toxicity involving protein conformational changes that result in the formation and deposi...
109
click to vote
NAR
2011
13 years 6 months ago
2011
The Biological General Repository for Interaction Datasets (BioGRID) is a public database that archives and disseminates genetic and protein interaction data from model organisms ...
NAR
2011
13 years 6 months ago
2011
EcoCyc (http://EcoCyc.org) is a comprehensive model organism database for Escherichia coli K-12 MG1655. From the scientific literature, EcoCyc captures the functions of individual...
NAR
2011
13 years 6 months ago
2011
The REDfly database of Drosophila transcriptional cis-regulatory elements provides the broadest and most comprehensive available resource for experimentally validated cis-regulato...
NAR
2011
13 years 6 months ago
2011
The Hymenoptera Genome Database (HGD) is a comprehensive model organism database that caters to the needs of scientists working on insect species of the order Hymenoptera. This sy...
NAR
2011
13 years 6 months ago
2011
COMBREX (http://combrex.bu.edu) is a project to increase the speed of the functional annotation of new bacterial and archaeal genomes. It consists of a database of functional pred...
NAR
2011
13 years 6 months ago
2011
The Protein–RNA Interface Database (PRIDB) is a comprehensive database of protein–RNA interfaces extracted from complexes in the Protein Data Bank (PDB). It is designed to fac...
NAR
2011
13 years 6 months ago
2011
The Pancreatic Expression database (PED, http:// www.pancreasexpression.org) has established itself as the main repository for pancreatic-derived -omics data. For the past 3 years...
NAR
2011
13 years 6 months ago
2011
The procedure of drug approval is time-consuming, costly and risky. Accidental findings regarding multispecificity of approved drugs led to block-busters in new indication areas. ...